<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39516528</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>08</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Transcutaneous electrical nerve stimulation for fibromyalgia-like syndrome in patients with Long-COVID: a pilot randomized clinical trial.</ArticleTitle><Pagination><StartPage>27224</StartPage><MedlinePgn>27224</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">27224</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-024-78651-5</ELocationID><Abstract><AbstractText>This study investigated the effect of Transcutaneous Electrical Nerve Stimulation (TENS) for fibromyalgia-like symptoms including chronic widespread musculoskeletal pain, fatigue, and/or gait impairment in twenty-five individuals with long-COVID. Participants were randomized to a high dose (intervention group, IG) or low dose (placebo group, PG) TENS device. Both groups received daily 3-5&#xa0;h of TENS therapy for 4-weeks. The Brief Pain Inventory assessed functional interference from pain (BPI-I), and pain severity (BPI-S). The global fatigue index (GFI) assessed functional interference from fatigue. Wearable technology measured gait parameters during three 30-feet consecutive walking tasks. At 4-weeks, the IG exhibited a greater decrease in BPI-I compared to the PG (mean difference&#x2009;=&#x2009;2.61, p&#x2009;=&#x2009;0.008), and improved in gait parameters including stride time (4-8%, test condition dependent), cadence (4-10%, depending on condition), and double-support phase (12% in dual-task) when compared to baseline. A sub-group meeting the 2010&#xa0;American College of Rheumatology Fibromyalgia diagnostic criteria undergoing high-dose TENS showed GFI improvement at 4-weeks from baseline (mean change&#x2009;=&#x2009;6.08, p&#x2009;=&#x2009;0.005). Daily TENS therapy showed potential in reducing functional interference from pain, fatigue, and gait alterations in long-COVID individuals. The study's limited power could affect the confirmation of certain observations. Extending the intervention period may improve treatment effectiveness.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zulbaran-Rojas</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bara</LastName><ForeName>Rasha O</ForeName><Initials>RO</Initials><AffiliationInfo><Affiliation>Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Myeounggon</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Advanced Surgical &amp; Interventional Technology (CASIT), Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles, 700 Westwood Plaza, Suite 2200, Los Angeles, CA, 90095, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bargas-Ochoa</LastName><ForeName>Miguel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phan</LastName><ForeName>Tina</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pacheco</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camargo</LastName><ForeName>Areli Flores</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kazmi</LastName><ForeName>Syed Murtaza</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rouzi</LastName><ForeName>Mohammad Dehghan</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Advanced Surgical &amp; Interventional Technology (CASIT), Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles, 700 Westwood Plaza, Suite 2200, Los Angeles, CA, 90095, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Modi</LastName><ForeName>Dipaben</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Critical Care, Baylor College of Medicine, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaib</LastName><ForeName>Fidaa</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Critical Care, Baylor College of Medicine, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Najafi</LastName><ForeName>Bijan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA. najafi.bijan@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Advanced Surgical &amp; Interventional Technology (CASIT), Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles, 700 Westwood Plaza, Suite 2200, Los Angeles, CA, 90095, USA. najafi.bijan@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004561" MajorTopicYN="Y">Transcutaneous Electric Nerve Stimulation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005356" MajorTopicYN="Y">Fibromyalgia</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005684" MajorTopicYN="N">Gait</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>BN is a consultant for BioSensics LLC (MA, USA) a manufacturer of the IMUs used in this study, who declares potential conflicts of interest regarding the research, authorship, and/or publication of this article. Although his consultation does not relate to the scope of this study, he was not involved in the analysis of data for this study. No additional potential conflicts of interest were reported. The disclosure for other authors is none.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>11</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>14</Day><Hour>3</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>13</Day><Hour>13</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>8</Day><Hour>23</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39516528</ArticleId><ArticleId IdType="pmc">PMC11549448</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-78651-5</ArticleId><ArticleId IdType="pii">10.1038/s41598-024-78651-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Raveendran, A., Jayadevan, R. &amp; Sashidharan, S. Long COVID: an overview. Diabetes Metab. Syndr. Clin. Res. Revi.15, 869&#x2013;875 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9637465</ArticleId><ArticleId IdType="pubmed">36351871</ArticleId></ArticleIdList></Reference><Reference><Citation>Control, C. D. &amp; Prevention Nearly one in five American adults who have had COVID-19 still have long COVID. Natl. Center Health Stat. 622 https://www.cdc.gov/nchs/pressroom/nchs_ (2022).</Citation></Reference><Reference><Citation>Sojka, A., Machniak, M., Andrzejewski, W., Kosendiak, A. &amp; Chwa&#x142;czy&#x144;ska, A. Changes in physical activity and the occurrence of specific symptoms of long-COVID syndrome in men aged 18&#x2013;25. Int. J. Environ. Res. Public Health19, 1199 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8834557</ArticleId><ArticleId IdType="pubmed">35162225</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoja, O. et al. Clinical characteristics and mechanisms of musculoskeletal pain in long COVID. J. Pain Res. 1729&#x2013;1748 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9212788</ArticleId><ArticleId IdType="pubmed">35747600</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker, A. M. et al. Addressing the post-acute sequelae of SARS-CoV-2 infection: a multidisciplinary model of care. Lancet Respir. Med.9, 1328&#x2013;1341 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8525917</ArticleId><ArticleId IdType="pubmed">34678213</ArticleId></ArticleIdList></Reference><Reference><Citation>Keklicek, H., Sel&#xe7;uk, H., Kurt, &#x130;., Ulukaya, S. &amp; &#xd6;zt&#xfc;rk, G. Individuals with a COVID-19 history exhibit asymmetric gait patterns despite full recovery. J. Biomech.137, 111098 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9011902</ArticleId><ArticleId IdType="pubmed">35460936</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitrovi&#x107;-Ajti&#x107;, O. et al. in Healthcare. (MDPI) (1666).</Citation></Reference><Reference><Citation>Gil, S. et al. Post-acute sequelae of SARS-CoV-2 associates with physical inactivity in a cohort of COVID-19 survivors. Sci. Rep.13, 215. 10.1038/s41598-022-26888-3 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9813883</ArticleId><ArticleId IdType="pubmed">36604523</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgmer, M. et al. Cerebral mechanisms of experimental hyperalgesia in fibromyalgia. Eur. J. Pain16, 636&#x2013;647 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22337349</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchdev, P. et al. Overview of the biomarkers reflecting inflammation and nutritional determinants of Anemia (BRINDA) project. Adv. Nutr.7, 349&#x2013;356 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4785469</ArticleId><ArticleId IdType="pubmed">26980818</ArticleId></ArticleIdList></Reference><Reference><Citation>Control, C., f., D. &amp; Prevention post-COVID conditions: Information for healthcare providers. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html (2024).</Citation></Reference><Reference><Citation>Plaut, S. &amp; Long COVID-19 and viral fibromyalgia-ness: suggesting a mechanistic role for fascial myofibroblasts (Nineveh, the shadow is in the fascia). Front. Med.10, 952278 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10117846</ArticleId><ArticleId IdType="pubmed">37089610</ArticleId></ArticleIdList></Reference><Reference><Citation>Ursini, F. et al. Fibromyalgia: a new facet of the post-COVID-19 syndrome spectrum? Results from a web-based survey. RMD Open7, e001735 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8384499</ArticleId><ArticleId IdType="pubmed">34426540</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordero, M. D. The inflammasome in fibromyalgia and CRPS: a microglial hypothesis? Nat. Rev. Rheumatol.11, 630&#x2013;630 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26416596</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Brien, A. T., Deitos, A., Pego, Y. T. &amp; Fregni, F. Carrillo-de-la-Pe&#xf1;a, M. T. Defective endogenous pain modulation in fibromyalgia: a meta-analysis of temporal summation and conditioned pain modulation paradigms. J. Pain19, 819&#x2013;836 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29454976</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams, D. A. &amp; Gracely, R. H. Biology and therapy of fibromyalgia. Functional magnetic resonance imaging findings in fibromyalgia. Arthritis Res. Ther.8, 1&#x2013;8 (2007).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1794529</ArticleId><ArticleId IdType="pubmed">17254318</ArticleId></ArticleIdList></Reference><Reference><Citation>Clough, E. et al. Mitochondrial dynamics in SARS-COV2 spike protein treated human microglia: implications for neuro-COVID. J. Neuroimmune Pharmacol., 1&#x2013;15 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8487226</ArticleId><ArticleId IdType="pubmed">34599743</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, S. et al. SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation. Signal. Transduct. Target. Ther.5, 235 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7545816</ArticleId><ArticleId IdType="pubmed">33037188</ArticleId></ArticleIdList></Reference><Reference><Citation>Panariello, F., Cellini, L., Speciani, M., De Ronchi, D. &amp; Atti, A. R. How does SARS-CoV-2 affect the central nervous system? A working hypothesis. Front. Psychiatr.11, 582345 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7701095</ArticleId><ArticleId IdType="pubmed">33304284</ArticleId></ArticleIdList></Reference><Reference><Citation>Atta, A. A., Ibrahim, W. W., Mohamed, A. F. &amp; Abdelkader N. F. Microglia polarization in nociplastic pain: mechanisms and perspectives. Inflammopharmacology31, 1053&#x2013;1067 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10229465</ArticleId><ArticleId IdType="pubmed">37069462</ArticleId></ArticleIdList></Reference><Reference><Citation>Berry, M. et al. Dynamic functional brain connectivity underlying temporal summation of pain in fibromyalgia. Arthritis Rheumatol.74, 700&#x2013;710 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34725971</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosch, B., Hagena, V., Herpertz, S. &amp; Diers, M. Brain morphometric changes in fibromyalgia and the impact of psychometric and clinical factors: a volumetric and diffusion-tensor imaging study. Arthritis Res. Ther.25, 81 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10197341</ArticleId><ArticleId IdType="pubmed">37208755</ArticleId></ArticleIdList></Reference><Reference><Citation>Scardua-Silva, L. et al. Microstructural brain abnormalities, fatigue, and cognitive dysfunction after mild COVID-19. Sci. Rep.14, 1758 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10798999</ArticleId><ArticleId IdType="pubmed">38242927</ArticleId></ArticleIdList></Reference><Reference><Citation>Fialho, M. F. P., Brum, E. S. &amp; Oliveira, S. M. Could the fibromyalgia syndrome be triggered or enhanced by COVID-19? Inflammopharmacology 31, 633&#x2013;651 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9970139</ArticleId><ArticleId IdType="pubmed">36849853</ArticleId></ArticleIdList></Reference><Reference><Citation>A Phase 2 study to evaluate the efficacy and safety of TNX-102 SL in patients with Multi-site Pain Associated with Post-acute Sequelae of SARS-CoV-2 (2023). Infection (PREVAIL).</Citation></Reference><Reference><Citation>Fern&#xe1;ndez-de&#x2010;las&#x2010;Pe&#xf1;as, C., Nijs, J., Giordano, R. &amp; Arendt&#x2010;Nielsen, L. Precision management of post&#x2010;COVID pain: an evidence and clinical&#x2010;based approach. Eur. J. Pain27, 1107&#x2013;1125 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36852606</ArticleId></ArticleIdList></Reference><Reference><Citation>DeSantana, J. M., Walsh, D. M., Vance, C., Rakel, B. A. &amp; Sluka, K. A. Effectiveness of transcutaneous electrical nerve stimulation for treatment of hyperalgesia and pain. Curr. Rheumatol. Rep.10, 492&#x2013;499 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2746624</ArticleId><ArticleId IdType="pubmed">19007541</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance, C. G., Dailey, D. L., Rakel, B. A. &amp; Sluka, K. A. using TENS for pain control: the state of the evidence. Pain Manag.4, 197&#x2013;209 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4186747</ArticleId><ArticleId IdType="pubmed">24953072</ArticleId></ArticleIdList></Reference><Reference><Citation>Gozani, S. N. Remote analgesic effects of conventional transcutaneous electrical nerve stimulation: a scientific and clinical review with a focus on chronic pain. J. pain Res., 3185&#x2013;3201 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6885653</ArticleId><ArticleId IdType="pubmed">31819603</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin, T., Gargya, A., Singh, H., Sivanesan, E. &amp; Gulati, A. Mechanism of peripheral nerve stimulation in chronic pain. Pain Med.21, S6&#x2013;S12 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7828608</ArticleId><ArticleId IdType="pubmed">32804230</ArticleId></ArticleIdList></Reference><Reference><Citation>Moayedi, M. &amp; Davis, K. D. Theories of pain: from specificity to gate control. J. Neurophysiol. (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23034364</ArticleId></ArticleIdList></Reference><Reference><Citation>Amer-Cuenca, J. J. et al. The dose-dependent effects of transcutaneous electrical nerve stimulation for pain relief in individuals with fibromyalgia: a systematic review and meta-analysis. Pain 10.1097 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36893318</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson, M. I., Claydon, L. S., Herbison, G. P., Jones, G. &amp; Paley, C. A. Transcutaneous electrical nerve stimulation (TENS) for fibromyalgia in adults. Cochrane Database Syst. Rev.10, Cd012172. 10.1002/14651858.CD012172.pub2 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6485914</ArticleId><ArticleId IdType="pubmed">28990665</ArticleId></ArticleIdList></Reference><Reference><Citation>Quell 2.0. Wearable pain relief technology TM User Manual. http://www.quellrelief.com/wp-content/uploads/2018/09/Quell-2.0-User-Manual-PN2204823-Rev-A.pdf (2018).</Citation></Reference><Reference><Citation>Jamison, R. N. et al. Effects of wearable transcutaneous electrical nerve stimulation on fibromyalgia: a randomized controlled trial. J. Pain Res. 2265&#x2013;2282 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8318714</ArticleId><ArticleId IdType="pubmed">34335055</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleeland, C. &amp; Ryan, K. Pain assessment: global use of the brief Pain Inventory. Ann. Acad. Med. Singapore23, 129&#x2013;138 (1994).</Citation><ArticleIdList><ArticleId IdType="pubmed">8080219</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuberger, G. B. Measures of fatigue: the fatigue questionnaire, fatigue severity scale, multidimensional assessment of fatigue scale, and short Form-36 vitality (Energy/Fatigue) subscale of the short Form Health Survey. Arthr. Rhuem.49, S175&#x2013;S183 (2003).</Citation></Reference><Reference><Citation>Merriwether, E. N. et al. Physical activity is related to function and fatigue but not pain in women with fibromyalgia: baseline analyses from the fibromyalgia activity study with TENS (FAST). Arthritis Res. Ther. 20, 199. (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6116369</ArticleId><ArticleId IdType="pubmed">30157911</ArticleId></ArticleIdList></Reference><Reference><Citation>Beauchet, O. et al. Walking speed-related changes in stride time variability: effects of decreased speed. J. Neuroeng. Rehabil. 6, 1&#x2013;6 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2731039</ArticleId><ArticleId IdType="pubmed">19656364</ArticleId></ArticleIdList></Reference><Reference><Citation>Deusen, J. V. Temporal and Distance Parameters, in Assessment in Occupational Therapy and Physical Therapy Chap. 17. (1996).</Citation></Reference><Reference><Citation>Lee, T., Lee, M., Youm, C., Noh, B. &amp; Park, H. Association between gait variability and gait-ability decline in elderly women with subthreshold insomnia stage. Int. J. Environ. Res. Public Health17, 5181 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7400183</ArticleId><ArticleId IdType="pubmed">32709118</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang, G. E., Zahiri, M., Lepow, B., Saleem, N. &amp; Najafi, B. The effect of daily use of plantar mechanical stimulation through micro-mobile foot compression device installed in shoe insoles on vibration perception, gait, and balance in people with diabetic peripheral neuropathy. J. Diabetes Sci. Technol.13, 847&#x2013;856 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6955449</ArticleId><ArticleId IdType="pubmed">30943782</ArticleId></ArticleIdList></Reference><Reference><Citation>Gewandter, J. S. et al. Wireless transcutaneous electrical nerve stimulation (TENS) for chronic chemotherapy-induced peripheral neuropathy (CIPN): a proof-of-concept randomized clinical trial. J. pain (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11058028</ArticleId><ArticleId IdType="pubmed">37993030</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesh, V. &amp; Davis, F. D. A theoretical extension of the technology acceptance model: four longitudinal field studies. Manag. Sci.46, 186&#x2013;204 (2000).</Citation></Reference><Reference><Citation>Jamison, R. N. et al. Effects of wearable transcutaneous electrical nerve stimulation on fibromyalgia: a randomized controlled trial. J. Pain Res.14, 2265&#x2013;2282. 10.2147/jpr.S316371 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8318714</ArticleId><ArticleId IdType="pubmed">34335055</ArticleId></ArticleIdList></Reference><Reference><Citation>Zulbaran-Rojas, A. et al. Optimizing tissue oxygenation in reduction mammoplasty: the role of continuous diffusion of oxygen: a feasibility pilot randomized controlled trial. J. Surg. Res.292, 113&#x2013;122 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37611440</ArticleId></ArticleIdList></Reference><Reference><Citation>Zulbaran-Rojas, A., Mishra, R., Pham, A., Suliburk, J. &amp; Najafi, B. Continuous diffusion of oxygen adjunct therapy to improve scar reduction after cervicotomy&#x2013;A proof of concept randomized controlled trial. J. Surg. Res.268, 585&#x2013;594 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34469858</ArticleId></ArticleIdList></Reference><Reference><Citation>Zulbaran-Rojas, A., Park, C., El-Refaei, N., Lepow, B. &amp; Najafi, B. Home-based electrical stimulation to accelerate wound healing&#x2014;a double-blinded randomized control trial. J. Diabetes Sci. Technol.17, 15&#x2013;24 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9846397</ArticleId><ArticleId IdType="pubmed">34328024</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfe, F. et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res.62, 600&#x2013;610 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20461783</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold, L. M. et al. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain119, 5&#x2013;15 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">16298061</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold, L. M., Gendreau, R. M., Palmer, R. H., Gendreau, J. F. &amp; Wang, Y. Efficacy and safety of milnacipran 100&#xa0;mg/day in patients with fibromyalgia: results of a randomized, double-blind, placebo&#x2010;controlled trial. Arthr. Rhuem.62, 2745&#x2013;2756 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20496365</ArticleId></ArticleIdList></Reference><Reference><Citation>Coskun Benlidayi, I. The effectiveness and safety of electrotherapy in the management of fibromyalgia. Rheumatol. Int.40, 1571&#x2013;1580 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32524302</ArticleId></ArticleIdList></Reference><Reference><Citation>Salaffi, F., Stancati, A., Silvestri, C. A., Ciapetti, A. &amp; Grassi, W. Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale. Eur. J. Pain8, 283&#x2013;291 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15207508</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed, M., Aamir, R., Jishi, Z. &amp; Scharf, M. B. The effects of milnacipran on sleep disturbance in fibromyalgia: a randomized, double-blind, placebo-controlled, two-way crossover study. J. Clin. Sleep. Med.12, 79&#x2013;86. 10.5664/jcsm.5400 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4702190</ArticleId><ArticleId IdType="pubmed">26414990</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong, X. &amp; Gozani, S. N. Effectiveness of fixed-site high-frequency transcutaneous electrical nerve stimulation in chronic pain: a large-scale, observational study. J. pain Res. 703&#x2013;714 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5898590</ArticleId><ArticleId IdType="pubmed">29670397</ArticleId></ArticleIdList></Reference><Reference><Citation>Azadvari, M., Haghparast, A., Nakhostin-Ansari, A., Razavi, S. Z. E. &amp; Hosseini, M. Musculoskeletal symptoms in patients with long COVID: a cross-sectional study on Iranian patients. Heliyon8 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9367176</ArticleId><ArticleId IdType="pubmed">35971463</ArticleId></ArticleIdList></Reference><Reference><Citation>Bormann, J., Shively, M., Smith, T. L. &amp; Gifford, A. L. Measurement of fatigue in HIV-Positive adults: reliability and validity of the global fatigue index. J. Assoc. Nurses AIDS Care12, 75&#x2013;83 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11387807</ArticleId></ArticleIdList></Reference><Reference><Citation>Stebbings, S., Herbison, P., Doyle, T., Treharne, G. J. &amp; Highton, J. A comparison of fatigue correlates in rheumatoid arthritis and osteoarthritis: disparity in associations with disability, anxiety and sleep disturbance. Rheumatology49, 361&#x2013;367 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">20007746</ArticleId></ArticleIdList></Reference><Reference><Citation>Straube, S., Derry, S., Moore, R. A. &amp; McQuay, H. J. Pregabalin in fibromyalgia: meta-analysis of efficacy and safety from company clinical trial reports. Rheumatology49, 706&#x2013;715 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20056767</ArticleId></ArticleIdList></Reference><Reference><Citation>Crofford, L. J. et al. Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin. Pain136, 419&#x2013;431 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18400400</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore, A. R. et al. Fibromyalgia: moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain. Pain149, 360&#x2013;364 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20347225</ArticleId></ArticleIdList></Reference><Reference><Citation>Dailey, D. L. et al. A randomized controlled trial of tens for movement-evoked pain in women with fibromyalgia. Arthritis Rheumatol. (Hoboken NJ)72, 824 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7188591</ArticleId><ArticleId IdType="pubmed">31738014</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrasco-Vega, E., Ruiz-Mu&#xf1;oz, M., Cuesta-Vargas, A., Romero-Galisteo, R. P. &amp; Gonz&#xe1;lez-S&#xe1;nchez, M. Individuals with fibromyalgia have a different gait pattern and a reduced walk functional capacity: a systematic review with meta-analysis. PeerJ10, e12908 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8944336</ArticleId><ArticleId IdType="pubmed">35341042</ArticleId></ArticleIdList></Reference><Reference><Citation>Heredia-Jimenez, J., Latorre-Roman, P., Santos-Campos, M., Orantes-Gonzalez, E. &amp; Soto-Hermoso, V. M. Spatio-temporal gait disorder and gait fatigue index in a six-minute walk test in women with fibromyalgia. Clin. Biomech. Elsevier Ltd.33, 1&#x2013;6 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26878719</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;n-Mart&#xed;nez, J. P. et al. Impact of cognitive tasks on biomechanical and kinematic parameters of gait in women with fibromyalgia: a cross-sectional study. Physiol. Behav.227, 113171 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32956683</ArticleId></ArticleIdList></Reference><Reference><Citation>Radunovi&#x107;, G. et al. Assessment of gait in patients with fibromyalgia during motor and cognitive dual task walking: a cross-sectional study. Adv. Rheumatol.61, 53 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34446109</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaleth, A. S., Slaven, J. E. &amp; Ang, D. C. Determining the minimal clinically important difference for 6-minute walk distance in fibromyalgia. Am. J. Phys. Med. Rehabil.95, 738&#x2013;745 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5831244</ArticleId><ArticleId IdType="pubmed">27003201</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvat, I. et al. Functional status, physical activity level, and exercise regularity in patients with fibromyalgia after multidisciplinary treatment: retrospective analysis of a randomized controlled trial. Rheumatol. Int.37, 377&#x2013;387 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">27844124</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiidus, P. M., Pierrynowski, M. &amp; Dawson, K. A. Influence of moderate training on gait and work capacity of fibromyalgia patients: a preliminary field study. J. Sports Sci. Med.1, 122 (2002).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3979003</ArticleId><ArticleId IdType="pubmed">24748843</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran, S. T. et al. A pilot study of biomechanical assessment before and after an integrative training program for adolescents with juvenile fibromyalgia. Pediatr. Rheumatol. Online J.14, 43. 10.1186/s12969-016-0103-7 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4957340</ArticleId><ArticleId IdType="pubmed">27448801</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin, S., Sun, Q., Wang, H. &amp; Xie, G. Influence of transcutaneous electrical nerve stimulation on spasticity, balance, and walking speed in stroke patients: a systematic review and meta-analysis. J. Rehabil. Med.50, 3&#x2013;7 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">28862711</ArticleId></ArticleIdList></Reference><Reference><Citation>Appelman, B. et al. Muscle abnormalities worsen after post-exertional malaise in long COVID. Nat. Commun.15, 1&#x2013;15 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10766651</ArticleId><ArticleId IdType="pubmed">38177128</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh, I. et al. Persistent exertional intolerance after COVID-19: insights from invasive cardiopulmonary exercise testing. Chest161, 54&#x2013;63 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8354807</ArticleId><ArticleId IdType="pubmed">34389297</ArticleId></ArticleIdList></Reference><Reference><Citation>Roskell, N. S., Beard, S. M., Zhao, Y. &amp; Le, T. K. A meta-analysis of pain response in the treatment of fibromyalgia. Pain Pract.11, 516&#x2013;527 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21199320</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold, L. M. et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum. Official J. Am. Coll. Rheumatol.50, 2974&#x2013;2984 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15457467</ArticleId></ArticleIdList></Reference><Reference><Citation>Orfei, M. D. et al. A new look on long-COVID effects: the functional brain fog syndrome. J. Clin. Med.11, 5529 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9573330</ArticleId><ArticleId IdType="pubmed">36233392</ArticleId></ArticleIdList></Reference><Reference><Citation>Dailey, D. L. et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain&#xae;154, 2554&#x2013;2562 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3972497</ArticleId><ArticleId IdType="pubmed">23900134</ArticleId></ArticleIdList></Reference><Reference><Citation>Zulbaran-Rojas, A. et al. Electrical stimulation to regain lower extremity muscle perfusion and endurance in patients with post&#x2010;acute sequelae of SARS CoV&#x2010;2: a randomized controlled trial. Physiol. Rep.11, e15636 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10006649</ArticleId><ArticleId IdType="pubmed">36905161</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>